Slide 1 Slide 2 Slide 3
Print this pageRefer to a friend

What We Do

ACTUS' strategy is to establish a subsidiary company for each licensed technology and to provide all of the financing, operational, research, development, and business partnering support the company requires during the initial stages of its development. In 2011, ACTUS established its first two subsidiary companies, Convoy Therapeutics, Inc. and EnduRx Pharmaceuticals, Inc., to develop and commercialize innovative platform technologies from University of California, Santa Barbara and the Sanford-Burnham Medical Research Institute. For further details, please visit our subsidiaries page.





Brings Key Innovations to Market

ACTUS Biotechnologies is a technology development company, founded with the aim of identifying and providing a bridge to the commercialization of the most transformative technologies and drug candidates in development at leading universities and research institutes in the U.S. Run by a Management Team with significant experience in Life Sciences and in the growth and financing of start-up businesses, ACTUS is well positioned to maximize the potential of the inventions it licenses.